Malaria Vaccines: Clinical Trials

3 trials of Malaria Vaccines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Terminated 1

Follow Malaria Vaccines: new trials by email Literature Review of Malaria Vaccines trials Research Report on Malaria Vaccines

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
GMZ2 (malaria vaccine), GMZ2 malaria vaccine, Verorab vaccine - Malaria
Phase 1UnknownAfrican Malaria Network Trust402007-06-012008-04-03
GMZ2-Aluminum Hydroxide Phase I, Tübingen
GMZ2 (GLURP + MSP3 Hybrid) (malaria vaccine) - Malaria
Phase 1UnknownEuropean Vaccine Initiative302006-10-012007-08-10
Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
Virosome-formulated synthetic peptides (malaria vaccine) - Falciparum Malaria
Phase 1TerminatedSwiss Tropical & Public Health Institute462003-11-012006-11-16

Conditions studied

Malaria (3)  ·  Malaria, Falciparum (1)

Sponsors

African Malaria Network Trust (1)  ·  European Vaccine Initiative (1)  ·  Swiss Tropical & Public Health Institute (1)

Countries

Gabon (1)  ·  Germany (1)

Top investigators

Peter Kremsner, MD, PhD (2)  ·  Blaise Genton, MD PhD (1)  ·  Jurgen Knobloch, MD (1)

Results publications

PMID 17925866, PMID 18060072